Aquatic Group Exercise for People With Parkinson Disease

Comparison of Aquatic and Land-based Group Exercise for Individuals With Parkinson Disease

This study will investigate the impact of land based or aquatic based group exercise on the balance, walking, balance confidence, and quality of life of people with idiopathic Parkinson disease. Participants will be randomized to participate in a land based or aquatic based group exercise program 2 times per week for 12 weeks. Prior to and after participation, balance, walking, quality of life, and balance confidence will be measured by a blinded examiner.

Study Overview

• Status: Terminated
• Conditions: Parkinson Disease
• Intervention / Treatment: Other: Aquatic Exercise; Other: Land Based Exercise

• Study Type: Interventional
• Enrollment (Actual): 5
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • New York
    • Ithaca, New York, United States, 14850
      • Ithaca College

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• adults over the age of 18 who have been diagnosed with idiopathic Parkinson disease.
• stable dose of levadopa medication for 30 days prior to study initiation
• able to walk 20 feet without physical assistance
• a referral from a physician to participate in physical therapy

Exclusion Criteria:

individuals with:

• uncontrolled cardiovascular or pulmonary conditions
• deep vein thrombosis in the last 6 months
• the use of breathing tube or feeding tube
• those with an extreme fear of exercising in the water
• an active dermatological condition (including eczema, psoriasis, or open wound) -any other neurological condition other than Parkinson disease
• a musculoskeletal condition that would impact their ability to participate in the exercise group
• cognitive impairment (a score of less than 24/30 on the Mini Mental Status Examination)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Aquatic Group Exercise	Other: Aquatic Exercise; Group exercise intervention will be held 2 times per week for 12 weeks and will include balance training, strengthening, gait training, and cardiovascular training.
Active Comparator: Land Based Group Exercise	Other: Land Based Exercise; Group exercise intervention will be held 2 times per week for 12 weeks and will include balance training, strengthening, gait training, and cardiovascular training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Mini-BESTest Score	The Mini-BESTest examines postural control. A higher scores means less balance impairment.	Prior to intervention, after 12 week intervention
Change in Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS): Part III	The Movement Disorders Society-Unified Parkinson Disease Rating Scale examines motor function for people with Parkinson disease. A higher score indicates higher motor impairment related to Parkinson disease.	Prior to intervention, after 12 week intervention
Change in Gait Speed	The 10 meter walk test will be examined at self selected and fast speeds to examine gait speed.	Prior to intervention, after 12 week intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change in Parkinson Disease Questionnaire-39 (PDQ-39)	The Parkinson disease questionnaire-39 measures quality of life for people with Parkinson disease. A higher score means more quality of life limitations related to Parkinson disease.	Prior to intervention, after 12 week intervention
Change in Falls Efficacy Scale-International.	The Falls Efficacy Scale-International measures a person's balance confidence. A higher score is related to worse balance confidence.	Prior to intervention, after 12 week intervention

Collaborators and Investigators

• Sponsor: Ithaca College
• Collaborators: Parkinson's Foundation

Study record dates

Study Major Dates

• Study Start (Actual): February 28, 2020
• Primary Completion (Actual): March 10, 2020
• Study Completion (Actual): March 10, 2020

Study Registration Dates

• First Submitted: February 26, 2020
• First Submitted That Met QC Criteria: February 27, 2020
• First Posted (Actual): March 2, 2020

Study Record Updates

• Last Update Posted (Actual): April 5, 2021
• Last Update Submitted That Met QC Criteria: March 31, 2021
• Last Verified: March 1, 2021

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Parkinsonian Disorders; Basal Ganglia Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases; Parkinson Disease
• Other Study ID Numbers: 711 (Ct Surgery Network Research Group)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Undecided

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No